Hazards of reducing cholesterolBMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6953.541 (Published 20 August 1994) Cite this as: BMJ 1994;309:541
- C Lines
- Merck, Sharp and Dohme Neuroscience Research Centre, Harlow, Essex CM20 2QR.
EDITOR, - The paper by Law and colleagues1 has given rise to further debate on the safety of cholesterol reduction. In particular, there has been speculation concerning a disputed increase in deaths from suicide and accidents,2 which might indicate detrimental effects on the central nervous system associated with lowering cholesterol.
Data gathered during the 8245 patient, 48 week, double blind, placebo controlled, parallel groups, expanded clinical evaluation of lovastatin (EXCEL) study are pertinent …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial